Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772
In the original publication [...]
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-02-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/16/5/1006 |
| _version_ | 1797264703424036864 |
|---|---|
| author | Riaz Jannoo William Walker Venkateswarlu Kanamarlapudi |
| author_facet | Riaz Jannoo William Walker Venkateswarlu Kanamarlapudi |
| author_sort | Riaz Jannoo |
| collection | DOAJ |
| description | In the original publication [...] |
| first_indexed | 2024-04-25T00:33:07Z |
| format | Article |
| id | doaj.art-2d5792ddd1194c3186d4c77114834a49 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-04-25T00:33:07Z |
| publishDate | 2024-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-2d5792ddd1194c3186d4c77114834a492024-03-12T16:41:11ZengMDPI AGCancers2072-66942024-02-01165100610.3390/cancers16051006Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772Riaz Jannoo0William Walker1Venkateswarlu Kanamarlapudi2UCL ECMC GCLP Facility, UCL Cancer Institute, University College London, London WC1E 6DD, UKInstitute of Life Science, School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UKInstitute of Life Science, School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UKIn the original publication [...]https://www.mdpi.com/2072-6694/16/5/1006n/a |
| spellingShingle | Riaz Jannoo William Walker Venkateswarlu Kanamarlapudi Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772 Cancers n/a |
| title | Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772 |
| title_full | Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772 |
| title_fullStr | Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772 |
| title_full_unstemmed | Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772 |
| title_short | Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772 |
| title_sort | correction jannoo et al targeting and sensitization of breast cancer cells to killing with a novel interleukin 13 receptor α2 specific hybrid cytolytic peptide i cancers i 2023 i 15 i 2772 |
| topic | n/a |
| url | https://www.mdpi.com/2072-6694/16/5/1006 |
| work_keys_str_mv | AT riazjannoo correctionjannooetaltargetingandsensitizationofbreastcancercellstokillingwithanovelinterleukin13receptora2specifichybridcytolyticpeptideicancersi2023i15i2772 AT williamwalker correctionjannooetaltargetingandsensitizationofbreastcancercellstokillingwithanovelinterleukin13receptora2specifichybridcytolyticpeptideicancersi2023i15i2772 AT venkateswarlukanamarlapudi correctionjannooetaltargetingandsensitizationofbreastcancercellstokillingwithanovelinterleukin13receptora2specifichybridcytolyticpeptideicancersi2023i15i2772 |